home / stock / cure:cc / cure:cc quote
Last: | $0.05 |
---|---|
Change Percent: | 0.0% |
Open: | $0.05 |
Close: | $0.05 |
High: | $0.05 |
Low: | $0.05 |
Volume: | 7,800 |
Last Trade Date Time: | 04/25/2022 04:56:06 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 7,800 | 04-25-2022 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 7,800 | 04-20-2022 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 1,819 | 04-19-2022 |
$0.05 | $0.055 | $0.05 | $0.055 | $0.05 | 4,000 | 04-08-2022 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 17,000 | 04-07-2022 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 4,861 | 04-06-2022 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 12,000 | 03-30-2022 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 1,000 | 03-28-2022 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 7,850 | 03-23-2022 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 6,048 | 03-16-2022 |
$0.055 | $0 | $0.055 | $0 | $0 | 237 | 03-14-2022 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 20,000 | 03-10-2022 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 3,700 | 03-09-2022 |
$0.045 | $0.05 | $0.045 | $0.05 | $0.045 | 15,000 | 03-04-2022 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 20,000 | 03-03-2022 |
$0.05 | $0.055 | $0.05 | $0.055 | $0.05 | 10,000 | 03-02-2022 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 15,017 | 03-01-2022 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 18,093 | 02-25-2022 |
$0.06 | $0.06 | $0.06 | $0.075 | $0.06 | 12,000 | 02-24-2022 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 38,028 | 02-23-2022 |
News, Short Squeeze, Breakout and More Instantly...
Biocure Technology Inc. Company Name:
CURE:CC Stock Symbol:
CNQC Market:
Canadian Investment Regulatory Organization Trade Resumption - CURE.X Canada NewsWire VANCOUVER, BC , July 4, 2024 /CNW/ - Trading resumes in: Company: Biocure Technology Inc. CSE Symbol: CURE.X All Issues: Yes Resumption (ET): 9:30 AM 7/5/2024 ...
Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics. Shareholders of Atriva ...
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that it has entered into an exclusive letter agreement dated September 8, 2023 with Atriva Therapeutics GmbH. ("Atriva") whereby the Company will acquire al...